Artivion to Present at Prestigious Morgan Stanley Global Healthcare Conference
Atlanta, GA – September 5, 2025 – Artivion, Inc. (NYSE: AOV), a leading global medical device company focused on developing innovative solutions for the treatment of aortic disease, announced today its participation in the Morgan Stanley 23rd Annual Global Healthcare Conference. The conference is scheduled to take place from September 8th to 10th, 2025, at the Venetian Palazzo Resort in Las Vegas, Nevada.
Artivion’s Chief Executive Officer, Owen W. Davis, will represent the company and deliver a presentation on Monday, September 8th, at 11:00 AM Pacific Time (2:00 PM Eastern Time). Mr. Davis will provide an overview of Artivion’s strategic priorities, highlight recent company achievements, and discuss the company’s outlook within the dynamic cardiovascular market. This presentation offers a valuable opportunity for investors, analysts, and healthcare professionals to gain deeper insights into Artivion’s innovative product portfolio and its commitment to advancing the treatment of aortic diseases.
The Morgan Stanley Global Healthcare Conference is a highly anticipated event that convenes key players in the healthcare industry, including leading public and private companies, investors, and industry experts. The conference serves as a platform for discussions on critical trends, emerging technologies, and future opportunities shaping the global healthcare landscape. Artivion’s inclusion in this prestigious event underscores its significant contributions and growing influence within the cardiovascular medicine sector.
Attendees of the conference will have the chance to engage directly with Artivion’s leadership and learn more about the company’s dedication to improving patient outcomes through its cutting-edge solutions. Artivion’s product offerings are designed to address a range of aortic conditions, offering physicians advanced tools to manage complex patient cases and enhance surgical precision.
For those unable to attend the conference in person, a webcast of Mr. Davis’s presentation will be accessible through the Investor Relations section of Artivion’s corporate website at www.artivion.com. A replay of the webcast will also be available on the website for a limited time following the presentation. This ensures that a broad audience can benefit from the insights shared by Artivion’s leadership.
Artivion remains committed to its mission of providing life-saving technologies to patients with aortic diseases, and its participation in the Morgan Stanley Global Healthcare Conference is a testament to its ongoing progress and strategic vision. The company looks forward to engaging with the wider healthcare community and sharing its latest developments.
Artivion to Participate in Morgan Stanley 23rd Annual Global Healthcare Conference
AI has delivered the news.
The answer to the following question is obtained from Google Gemini.
PR Newswire Healthring published ‘Artivion to Participate in Morgan Stanley 23rd Annual Global Healthcare Conference’ at 2025-09-05 20:10. Please write a detailed article about this news in a polite tone with relevant information. Please reply in English with the article only.